Tillkännagivande • Feb 13
MSC Co., Ltd., Annual General Meeting, Mar 27, 2026 MSC Co., Ltd., Annual General Meeting, Mar 27, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 45-73, sojuhoeya-ro, gyeongsangnam-do, yangsan South Korea Upcoming Dividend • Dec 22
Upcoming dividend of ₩110 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 27 April 2026. Payout ratio is a comfortable 8.0% and this is well supported by cash flows. Trailing yield: 1.3%. Lower than top quartile of South Korean dividend payers (3.6%). In line with average of industry peers (1.3%). Reported Earnings • Nov 20
Third quarter 2025 earnings released: EPS: ₩305 (vs ₩327 in 3Q 2024) Third quarter 2025 results: EPS: ₩305 (down from ₩327 in 3Q 2024). Revenue: ₩51.8b (up 10% from 3Q 2024). Net income: ₩5.37b (down 6.8% from 3Q 2024). Profit margin: 10% (down from 12% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 14% per year. New Risk • Nov 14
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩145.0b (US$99.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Market cap is less than US$100m (₩145.0b market cap, or US$99.5m). Declared Dividend • Nov 08
Dividend of ₩110 announced Dividend of ₩110 is the same as last year. Ex-date: 29th December 2025 Payment date: 27th April 2026 Dividend yield will be 1.2%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is well covered by both earnings (8% earnings payout ratio) and cash flows (7% cash payout ratio). The dividend has increased by an average of 18% per year over the past 8 years and payments have been stable during that time. Earnings per share has grown by 16% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Tillkännagivande • Nov 07
MSC Co., Ltd. announces Annual dividend, payable on April 27, 2026 MSC Co., Ltd. announced Annual dividend of KRW 110.0000 per share payable on April 27, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. Valuation Update With 7 Day Price Move • Sep 12
Investor sentiment improves as stock rises 33% After last week's 33% share price gain to ₩12,490, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 134% over the past three years. New Risk • Aug 28
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Aug 28
Investor sentiment improves as stock rises 32% After last week's 32% share price gain to ₩10,770, the stock trades at a trailing P/E ratio of 7.9x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 94% over the past three years. New Risk • Jul 28
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩137.8b (US$99.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩137.8b market cap, or US$99.5m). Valuation Update With 7 Day Price Move • Jul 10
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩10,420, the stock trades at a trailing P/E ratio of 7.6x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 88% over the past three years. New Risk • Jun 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Jun 16
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₩10,260, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 89% over the past three years. Valuation Update With 7 Day Price Move • May 16
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₩7,930, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years. Reported Earnings • Mar 26
Full year 2024 earnings released: EPS: ₩1,237 (vs ₩1,049 in FY 2023) Full year 2024 results: EPS: ₩1,237 (up from ₩1,049 in FY 2023). Revenue: ₩189.8b (flat on FY 2023). Net income: ₩21.8b (up 18% from FY 2023). Profit margin: 12% (up from 9.8% in FY 2023). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Tillkännagivande • Feb 14
MSC Co., Ltd., Annual General Meeting, Mar 28, 2025 MSC Co., Ltd., Annual General Meeting, Mar 28, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 45-73, sojuhoeya-ro, gyeongsangnam-do, yangsan South Korea Upcoming Dividend • Dec 20
Upcoming dividend of ₩100.00 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 28 April 2025. Payout ratio is a comfortable 5.6% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%). New Risk • Dec 09
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩94.0b market cap, or US$66.1m). Reported Earnings • Nov 20
Third quarter 2024 earnings released: EPS: ₩327 (vs ₩243 in 3Q 2023) Third quarter 2024 results: EPS: ₩327 (up from ₩243 in 3Q 2023). Revenue: ₩47.0b (down 1.6% from 3Q 2023). Net income: ₩5.76b (up 35% from 3Q 2023). Profit margin: 12% (up from 8.9% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Oct 10
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to ₩6,500, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 8.7% over the past three years. New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩88.5b market cap, or US$67.3m). Valuation Update With 7 Day Price Move • Jun 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₩5,990, the stock trades at a trailing P/E ratio of 6x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 5.2% over the past three years. Upcoming Dividend • Dec 20
Upcoming dividend of ₩60.00 per share at 1.1% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 29 April 2024. Payout ratio is a comfortable 5.7% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%). Reported Earnings • Nov 19
Third quarter 2023 earnings released: EPS: ₩243 (vs ₩281 in 3Q 2022) Third quarter 2023 results: EPS: ₩243 (down from ₩281 in 3Q 2022). Revenue: ₩47.7b (down 13% from 3Q 2022). Net income: ₩4.27b (down 14% from 3Q 2022). Profit margin: 8.9% (down from 9.0% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 17
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩6,300, the stock trades at a trailing P/E ratio of 6.1x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 51% over the past three years. New Risk • Jul 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (₩131.5b market cap, or US$99.8m). Valuation Update With 7 Day Price Move • Jun 30
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to ₩7,470, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 77% over the past three years. Reported Earnings • May 20
First quarter 2023 earnings released: EPS: ₩276 (vs ₩265 in 1Q 2022) First quarter 2023 results: EPS: ₩276 (up from ₩265 in 1Q 2022). Revenue: ₩49.0b (up 12% from 1Q 2022). Net income: ₩4.85b (up 3.9% from 1Q 2022). Profit margin: 9.9% (in line with 1Q 2022). Revenue is forecast to grow 7.0% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Dec 21
Upcoming dividend of ₩60.00 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. Payout ratio is a comfortable 6.2% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%). Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 1 independent director (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 05
Investor sentiment improved over the past week After last week's 23% share price gain to ₩6,170, the stock trades at a trailing P/E ratio of 6.7x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 19% over the past three years. Buying Opportunity • Sep 28
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 12%. The fair value is estimated to be ₩6,318, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.8% over the last 3 years. Earnings per share has grown by 15%. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 1 independent director (7 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Upcoming Dividend • Dec 22
Upcoming dividend of ₩60.00 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. Payout ratio is a comfortable 7.4% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.5%). Valuation Update With 7 Day Price Move • Aug 18
Investor sentiment improved over the past week After last week's 15% share price gain to ₩6,480, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total loss to shareholders of 1.4% over the past three years. Is New 90 Day High Low • Feb 18
New 90-day high: ₩5,180 The company is up 8.0% from its price of ₩4,790 on 20 November 2020. The South Korean market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 26% over the same period. Tillkännagivande • Feb 11
MSC Co., Ltd., Annual General Meeting, Mar 26, 2021 MSC Co., Ltd., Annual General Meeting, Mar 26, 2021, at 10:00 Korea Standard Time. Location: Our training room, 45-73, Sojuhoeya-ro, Yangsan-si Yangsan Si South Korea Is New 90 Day High Low • Jan 26
New 90-day high: ₩5,140 The company is up 10.0% from its price of ₩4,675 on 28 October 2020. The South Korean market is up 36% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 43% over the same period. Is New 90 Day High Low • Oct 07
New 90-day high: ₩5,570 The company is up 28% from its price of ₩4,360 on 09 July 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 32% over the same period.